D-0617-2017 Class II Terminated

Recalled by Zydus Pharmaceuticals USA Inc — Pennington, NJ

FDA drug recall D-0617-2017 was initiated by Zydus Pharmaceuticals USA Inc on Mar 15, 2017 and is designated Class II. Reason for recall: Failed Dissolution Specifications; 9 month long term stability The recall status is terminated (terminated Sep 10, 2020). Affected quantity: 32628 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 5, 2017
Initiation Date
Mar 15, 2017
Termination Date
Sep 10, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
32628 bottles

Product description

Divalproex Sodium Delayed Release Tablets, USP, 500 mg, a) 100 count (NDC 68382-033-01) and b) 500 count (NDC 68382-033-05) bottles, Rx only, manufactured by Cadila Healthcare Ltd, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals, Pennington, NJ

Reason for recall

Failed Dissolution Specifications; 9 month long term stability

Distribution pattern

Nationwide

Code information

a) MR8221, MR8222 exp 7/31/2017; MR10260, exp 9/30/2017; MR10926, exp 10/31/2017; b) MR6187, exp 5/31/2017; MR7302, exp 6/30/2017; MR7768, MR7769, exp 7/31/2017; MR8247, exp 7/31/2017; MR8887, MR8892, MR8893 exp 8/31/2017; MR9014, MR10414 exp 9/30/2017; MR10928, exp 10/31/2017; MR11183, MR11185, MR11186, exp 11/30/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0617-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0617-2017. Report a data issue: hello@regdatalab.com.